fluorescein has been researched along with Choroid Neovascularization in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (7.41) | 18.2507 |
| 2000's | 15 (55.56) | 29.6817 |
| 2010's | 9 (33.33) | 24.3611 |
| 2020's | 1 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, JY; Choi, SW; Hong, HK; Jeon, J; Kim, M; Kim, P; Lee, BC; Woo, SJ | 1 |
| Blobner, K; Feucht, N; Lohmann, CP; Maier, M; Pauleikhoff, LJB; Wehrmann, K | 1 |
| Bandello, F; Battaglia Parodi, M; Iacono, P; Romano, F | 1 |
| Guthrie, MJ; Kang-Mieler, JJ; Mieler, WF; Osswald, CR; Valio, NL | 1 |
| Wigg, JP; Yang, D; Zhang, H | 1 |
| Harding, SP; Soubrane, G; Weichselberger, A; Wolf, S | 1 |
| Francis, JH; Inoue, Y; Iriyama, A; Ishii, N; Mizuguchi, E; Obata, R; Oikawa, N; Takahashi, H; Tamaki, Y; Yanagi, Y | 1 |
| Bazan, NG; Elison, JR; Ertel, MK; Gjorstrup, P; Gordon, WC; Knott, EJ; Regan, CE; Sheets, KG; Zhou, Y | 1 |
| Bressler, NM; Dupas, B; Khurana, RN | 1 |
| Iriyama, A; Ishii, T; Kataoka, K; Nishiyama, N; Oba, M; Tamaki, Y; Yanagi, Y | 1 |
| Chung, H; Kwon, OW; Lai, CC; Lee, FL; Sheu, SJ; Yoon, YH | 1 |
| Bandello, F; Casalino, G; Gimeno, AT; Introini, U; Querques, G; Scotti, F | 1 |
| Adamis, AP; Ambati, BK; Ambati, J; Anand, A; Gragoudas, ES; Miller, JW; Sakurai, E; Taguchi, H | 1 |
| Lee, PJ; Peyman, GA | 1 |
| Chen, H; Chen, L; Ge, J; Jiang, R; Jin, C; Zhong, X; Zhou, S | 1 |
| Muranaka, K; Takahashi, H; Tamaki, Y; Uchida, S; Yanagi, Y | 1 |
| Connolly, E; Gragoudas, ES; Hafezi-Moghadam, A; Kaplan, M; Lane, AM; Mallemadugula, S; Michaud, N; Miller, JW; Nakazawa, T; Zambarakji, HJ | 1 |
| Azad, RV; Baishya, B; Kumar, A; Pal, N; Sharma, YR; Vohra, R | 1 |
| Obata, R; Takahashi, H; Tamaki, Y | 1 |
| Bressler, NM; Gilson, MM; Jabs, DA; Solomon, SD; Thorne, JE; Wilson, DJ | 1 |
| Barbazetto, I; Birngruber, R; Bressler, NM; Donati, G; Fsadni, M; Gragoudas, ES; Gray, T; Lane, AM; Laqua, H; Manjuris, U; Miller, JW; Piguet, B; Pournaras, CJ; Schmidt-Erfurth, U; Sickenberg, M; Strong, A; van den Berg, H; Zografos, L | 1 |
| Barbazetto, I; Birngruber, R; Bressler, NM; Donati, G; Fsadni, M; Gragoudas, ES; Gray, T; Lane, AM; Laqua, H; Manjuris, U; Miller, JW; Piguet, B; Pournaras, CJ; Schmidt-Erfurth, U; Sickenberg, M; Strong, HA; van den Berg, H; Zografos, L | 1 |
| Blumenkranz, MS; Kessel, D; Miller, R; Qing, F; Verdooner, S; Woodburn, KW | 1 |
| Klein, ML; Lauer, AK; Wilson, DJ | 1 |
| Ferrer Novella, E; Honrubia López, FM; Melcon Sánchez-Friera, B; Ruiz Moreno, O; Torrón Fernández-Blanco, C | 1 |
| Honda, Y; Kamizuru, H; Kimura, H; Ogura, Y; Tabata, Y; Yasukawa, T | 1 |
| Dohrmann, J; Lommatzsch, A; Müller, C; Pauleikhoff, D; Radermacher, M; Spital, G | 1 |
5 trial(s) available for fluorescein and Choroid Neovascularization
| Article | Year |
|---|---|
Verteporfin therapy in occult with no classic CNV due to AMD: results of the Photodynamic Therapy in Occult-Only Lesions study.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Female; Fluorescein; Fluorescein Angiography; Humans; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Verteporfin; Visual Acuity | 2009 |
EXTEND III: efficacy and safety of ranibizumab in South Korean and Taiwanese patients with subfoveal CNV secondary to AMD.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Capillary Permeability; Choroidal Neovascularization; Female; Fluorescein; Fovea Centralis; Humans; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Ranibizumab; Republic of Korea; Taiwan; Treatment Outcome; Visual Acuity | 2012 |
Periocular triamcinolone and photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration.
Topics: Aged; Capillary Permeability; Choroidal Neovascularization; Female; Fluorescein; Fluorescein Angiography; Fluorescent Dyes; Fovea Centralis; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body | 2007 |
Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.
Topics: Aged; Aged, 80 and over; Capillary Permeability; Choroid; Choroidal Neovascularization; Female; Fluorescein; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Refraction, Ocular; Safety; Treatment Outcome; Verteporfin; Visual Acuity | 1999 |
Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.
Topics: Aged; Aged, 80 and over; Capillary Permeability; Choroid; Choroidal Neovascularization; Female; Fluorescein; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retreatment; Safety; Treatment Outcome; Verteporfin; Visual Acuity | 1999 |
22 other study(ies) available for fluorescein and Choroid Neovascularization
| Article | Year |
|---|---|
FITC-Labeled RGD Peptides as Novel Contrast Agents for Functional Fluorescent Angiographic Detection of Retinal and Choroidal Neovascularization.
Topics: Choroidal Neovascularization; Coloring Agents; Contrast Media; Endothelial Cells; Fluorescein; Fluorescein-5-isothiocyanate; Humans; Oligopeptides | 2023 |
[Fluorescein, indocyanine green and optical coherence tomography angiography in patients with native exudative age-related macular degeneration].
Topics: Choroidal Neovascularization; Fluorescein; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Tomography, Optical Coherence | 2018 |
Fluorescein Leakage and Optical Coherence Tomography Features of Choroidal Neovascularization Secondary to Pathologic Myopia.
Topics: Angiogenesis Inhibitors; Capillary Permeability; Choroid; Choroidal Neovascularization; Female; Fluorescein; Fluorescein Angiography; Humans; Intravitreal Injections; Male; Middle Aged; Myopia, Degenerative; Prospective Studies; Ranibizumab; Subretinal Fluid; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2018 |
Objective area measurement technique for choroidal neovascularization from fluorescein angiography.
Topics: Animals; Bruch Membrane; Choroidal Neovascularization; Dexamethasone; Fluorescein; Fluorescein Angiography; Humans; Hydrogels; Image Processing, Computer-Assisted; Intravitreal Injections; Lasers; Macular Degeneration; Male; Nanospheres; Rats; Rats, Long-Evans; Triamcinolone Acetonide | 2014 |
A Quantitative and Standardized Method for the Evaluation of Choroidal Neovascularization Using MICRON III Fluorescein Angiograms in Rats.
Topics: Angiography; Animals; Choroidal Neovascularization; Disease Models, Animal; Fluorescein; Image Processing, Computer-Assisted; Macular Degeneration; Rats | 2015 |
Identification of a novel vascular endothelial growth factor receptor 2 inhibitor and its effect for choroidal neovascularization in vivo.
Topics: Administration, Oral; Angiogenesis Inhibitors; Angiography; Animals; Cell Proliferation; Cells, Cultured; Choroidal Neovascularization; Dose-Response Relationship, Drug; Endothelial Cells; Fluorescein; Fluorescent Dyes; Humans; Mice; Mice, Inbred C57BL; Phosphorylation; Vascular Endothelial Growth Factor Receptor-2 | 2008 |
Neuroprotectin D1 attenuates laser-induced choroidal neovascularization in mouse.
Topics: Animals; Cell Proliferation; Cell Size; Choroidal Neovascularization; Docosahexaenoic Acids; Endothelial Cells; Fluorescein; Fluorescein Angiography; Fundus Oculi; Lasers; Male; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Retina | 2010 |
Agreement of time-domain and spectral-domain optical coherence tomography with fluorescein leakage from choroidal neovascularization.
Topics: Aged; Capillary Permeability; Choroid; Choroidal Neovascularization; False Positive Reactions; Fluorescein; Fluorescein Angiography; Humans; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2010 |
Gene transfer using micellar nanovectors inhibits choroidal neovascularization in vivo.
Topics: Animals; Bacterial Proteins; Choroidal Neovascularization; Disease Models, Animal; Disease Progression; DNA; Fluorescein; Gene Transfer Techniques; Genetic Vectors; Laser Coagulation; Light Coagulation; Luminescent Proteins; Macular Degeneration; Male; Mice; Mice, Inbred C57BL; Micelles; Microscopy, Fluorescence; Polymers | 2011 |
Spectral-domain OCT in anti-VEGF treatment of myopic choroidal neovascularization.
Topics: Adult; Aged; Angiogenesis Inhibitors; Choroidal Neovascularization; Female; Fluorescein; Humans; Male; Middle Aged; Myopia; Prospective Studies; Sensitivity and Specificity; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A | 2012 |
Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization.
Topics: Animals; Capillary Permeability; CD18 Antigens; Choroidal Neovascularization; Fluorescein; Fluorescein Angiography; Gene Deletion; Gene Targeting; Intercellular Adhesion Molecule-1; Laser Coagulation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Confocal; Up-Regulation | 2003 |
Visualization of the retinal and choroidal microvasculature by fluorescent liposomes.
Topics: Animals; Blood Flow Velocity; Choroidal Neovascularization; Fluorescein; Humans; Indocyanine Green; Liposomes; Radiography; Retinal Neovascularization; Retinal Vessels; Staining and Labeling | 2003 |
Photodynamic therapy for age-related macular degeneration.
Topics: Aged; Choroidal Neovascularization; Female; Fluorescein; Fluorescein Angiography; Follow-Up Studies; Humans; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retrospective Studies; Tomography, Optical Coherence; Verteporfin | 2004 |
COX-2-selective inhibitor, etodolac, suppresses choroidal neovascularization in a mice model.
Topics: Angiography; Animals; Choroidal Neovascularization; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Etodolac; Female; Fluorescein; Immunohistochemistry; Isoenzymes; Mice; Mice, Inbred C57BL; Microscopy; Prostaglandin-Endoperoxide Synthases; Rats; Retina | 2004 |
Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of choroidal neovascularization.
Topics: Animals; Cholesterol; Choroidal Neovascularization; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Fluorescein; Fluorescein Angiography; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Mice, Inbred C57BL; Permeability; Quinolines; Retina; Vascular Endothelial Growth Factor A | 2006 |
Comparative evaluation of oral fluorescein angiography using the confocal scanning laser ophthalmoscope and digital fundus camera with intravenous fluorescein angiography using the digital fundus camera.
Topics: Administration, Oral; Choroidal Neovascularization; Contrast Media; Diabetic Retinopathy; Fluorescein; Fluorescein Angiography; Humans; Injections, Intravenous; Lasers; Ophthalmoscopes; Photography; Retinal Vessels | 2006 |
A novel vascular endothelial growth factor receptor 2 inhibitor, SU11248, suppresses choroidal neovascularization in vivo.
Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Capillary Permeability; Choroidal Neovascularization; Disease Models, Animal; Disease Progression; Female; Fluorescein; Fluorescein Angiography; Indoles; Mice; Mice, Inbred C57BL; Pyrroles; Sunitinib; Vascular Endothelial Growth Factor Receptor-2 | 2006 |
Lutetium texaphyrin (Lu-Tex): a potential new agent for ocular fundus angiography and photodynamic therapy.
Topics: Animals; Choroid; Choroidal Neovascularization; Disease Models, Animal; Fluorescein; Fluorescein Angiography; Fundus Oculi; Indocyanine Green; Lutetium; Male; Metalloporphyrins; Photochemotherapy; Photosensitizing Agents; Rabbits; Retinal Neovascularization; Retinal Vessels | 2000 |
Clinicopathologic correlation of fluorescein and indocyanine green angiography in exudative age-related macular degeneration.
Topics: Aged; Bruch Membrane; Choroidal Neovascularization; Exudates and Transudates; Fluorescein; Fluorescein Angiography; Fundus Oculi; Humans; Indocyanine Green; Laser Coagulation; Macular Degeneration; Male; Retina; Visual Acuity | 2000 |
[Indocyanine green angiography and subretinal neovascularization. Patterns in age related macular degeneration].
Topics: Aged; Aged, 80 and over; Aging; Analog-Digital Conversion; Choroidal Neovascularization; Disease Progression; Female; Fluorescein; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Male; Middle Aged; Radiography | 2001 |
Monoclonal antibody-mediated drug targeting to choroidal neovascularization in the rat.
Topics: Animals; Antibodies, Monoclonal; Capillary Permeability; Cell Division; Cells, Cultured; Choroid; Choroidal Neovascularization; Dextrans; Drug Delivery Systems; Endothelium, Vascular; Fluorescein; Fluorescein Angiography; Humans; Immunoconjugates; Male; Mitomycin; Models, Animal; Rats; Rats, Inbred BN; Receptors, Vitronectin; Umbilical Veins | 2001 |
[Pigment epithelium detachments in AMD (age-associated macular degeneration) and "polypoid choroidal vasculopathy". A fluorescein and indocyanine green angiography study].
Topics: Aged; Aged, 80 and over; Aneurysm; Choroid; Choroidal Neovascularization; Female; Fluorescein; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Male; Middle Aged; Retinal Detachment; Sensitivity and Specificity | 2002 |